ChartRow logo
Share this page
ARWR
$64.19-0.93%
as of close, Oct 2, 2026
☾ AH $64.19 -0.93%
Arrowhead Pharmaceuticals Inc.Stock · Health CareNasdaq Composite 0.02%Russell 1000 0.02%US Stock Market 0.02%Russell 3000 0.01%
PeersMRNALLYUNHJNJMRKTMO

Arrowhead Pharmaceuticals Inc. trailing returns

Arrowhead Pharmaceuticals Inc.'s 10-year return is +24.2% a year (CAGR) (+773.3% cumulative). How Arrowhead Pharmaceuticals Inc. (ARWR) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.

Trailing returns by period#

To 2026-10-02. Annualized (CAGR) for windows of a year or more.

PeriodPathAnnualizedCumulative
1 day—-0.9%
5 days—-2.6%
1 month—-24.8%
YTD—-3.3%
1 year
+85.5%
+85.5%
5 years
+0.5%
+2.5%
10 years
+24.2%
+773.3%
20 years
+1.5%
+35.1%
Since inception (1993)
-11.0%
-97.8%

Growth of ARWR

Actual index level (solid); dashed lines are each window's constant-rate path from start to today.

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from ARWR's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Arrowhead Pharmaceuticals Inc.'s 10-year return?
Over the last 10 years, Arrowhead Pharmaceuticals Inc. (ARWR) returned about +24.2% a year annualized (+773.3% cumulative total return).
What is Arrowhead Pharmaceuticals Inc.'s 20-year annualized return?
Over the last 20 years, Arrowhead Pharmaceuticals Inc. (ARWR) compounded at about +1.5% a year (+35.1% cumulative).
What is Arrowhead Pharmaceuticals Inc.'s return since inception?
Since 1993, Arrowhead Pharmaceuticals Inc. (ARWR) has compounded at about -11.0% a year — -97.8% in total.

More on Arrowhead Pharmaceuticals Inc.